Companies: 10,795·Total market cap: $144.5T
Novo Nordisk A/S

Novo Nordisk A/S

NVONYSEHealthcare● Active
$42.96
$-0.79(-1.81%)
Market Cap$190.9B
P/E Ratio—
52W High$81.44
52W Low$35.12
Net IncomeFinancialsRevenue

Novo Nordisk A/S (NVO) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

NVO · net income · updated Jun 8, 2026

Core profitability metrics

Net income was $102.43B for FY2025 (fiscal year ending 2025-12-31), up 1.4% year-over-year. Net profit margin was 33.1%. Based on available data, Novo Nordisk A/S has been profitable since at least 2011.

FY2025 Net Income$102.43B▲ +1.4% YoY
Trailing 12M (TTM)$121.96Btrailing 4 quarters sum
Net Profit Margin33.1%$102.43B ÷ $309.06B
YoY Change+1.4%—
5-Year CAGR+19.4%FY2020 → FY2025
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · NVO net income history · NVO profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025$102.43B▲ +1.4%33.1%
FY2024$100.99B▲ +20.7%34.8%
FY2023$83.68B▲ +50.7%36.0%
FY2022$55.52B▲ +16.3%31.4%
FY2021$47.76B▲ +13.3%33.9%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
Novo Nordisk A/S
Novo Nordisk A/SYOU
NVO
$102.43B+1.4%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Novo Nordisk A/S (NVO) reported net income of $102.43B for FY2025 (fiscal year ending 2025-12-31), up 1.4% year-over-year. The net profit margin was 33.1% — meaning the company kept $0.33 of every dollar of revenue as profit.

Based on available data, Novo Nordisk A/S has been profitable since at least 2011. Net income reached a peak of $102.43B in FY2025. Data available for 15 fiscal years.

Novo Nordisk A/S's net profit margin was 33.1% for FY2025, based on the latest annual results.

Investors sometimes search for "Novo Nordisk A/S net worth" — the company's market capitalization is a separate figure from NVO net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.
RevenueFinancial statementsEarningsForecastPrice historyMarket capFree cash flow

Frequently asked questions

NVO net income · 5 questions

Novo Nordisk A/S is profitable. The company reported net income of $102.43B for FY2025, a net profit margin of 33.1%. Net income was up 1.4% year-over-year. Based on available data, Novo Nordisk A/S has been profitable since at least 2011.

is NVO profitabledoes NVO make a profitNVO profitabilityNVO profitable company

▸ Source: FMP /income-statement · GAAP · Novo Nordisk A/S · Novo Nordisk A/S SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026